June 26, 2014 — The wife of a man who bled to death after taking Xarelto (rivaroxaban) has filed a lawsuit against the drug-maker Janssen Pharmaceuticals, a unit of Johnson & Johnson, for failing to warn that Xarelto can cause uncontrollable bleeding.
The lawsuit (PDF) was filed in federal court in Florida by Nancy Packard. Her husband, William N. Packard, Jr., started taking Xarelto in January 2012 to treat atrial fibrillation, which is a type of heart “flutter” that can cause blood clots and strokes. Xarelto was approved for this purpose in November 2011.
After taking Xarelto for about six months, Mr. Packard developed bleeding in his brain (subdural hemorrhage) and was admitted to a hospital. Doctors were unable to stop the bleeding, even after drilling a right frontal burr hole in his skull. The bleeding ultimately caused or contributed to his death on June 28, 2012.
Unlike warfarin, a blood-thinner that can be de-activated with a dose of Vitamin K, Xarelto has no antidote. In an emergency situation, doctors might struggle to stop bleeding because a patient’s blood is unable to clot. Despite these life-threatening risks, Xarelto lacks a “Black Box” warning about irreversible bleeding.
According to the complaint:
“Defendants failed to adequately warn about the lack of an antidote to reverse uncontrolled bleeding caused by Xarelto®. Defendants merely indicated that there was a risk for bleeding and side-stepped the important issue of reversing the effects of Xarelto® should a bleed occur. Other safer alternatives to Xarelto® have an antidote that can reverse uncontrolled bleeding.”
Janssen and Johnson & Johnson are accused of failing to warn doctors and patients about the “extreme risks” posed by Xarelto. Similar allegations have been raised against Boehringer Inhelheim, which recently paid $650 million to settle thousands of lawsuits involving Pradaxa (dabigatran). Xarelto has been linked to hundreds of adverse events involving severe, uncontrollable bleeding.
Do I have a Xarelto Lawsuit?
The Schmidt Firm, PLLC is currently accepting Xarelto induced injury cases in all 50 states. If you or somebody you know has been injured by severe bleeding, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.